Evidence map›Paper›PMID 41743086›Full record

ArticleFrontiers in medicine2026

Non-linear relationship between high-density lipoprotein cholesterol and metabolic dysfunction-associated steatotic liver disease: a cross-sectional study in the Japanese population.

Xiang Guo, Yucong Zou, Cui Yang, Changchun Cao, Yulong Wang, Fubing Zha

Abstract read
In one paragraph

Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Xiang Guo *Department of Rehabilitation, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University, Shenzhen, Guangdong, China.
Yucong Zou *Department of Rehabilitation, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University, Shenzhen, Guangdong, China.
Cui Yang *Department of Rehabilitation, Shenzhen Dapeng New District Nan'ao People's Hospital, Shenzhen, Guangdong, China.
Changchun CaoDepartment of Rehabilitation, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University, Shenzhen, Guangdong, China.
Yulong WangDepartment of Rehabilitation, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University, Shenzhen, Guangdong, China.
Fubing ZhaDepartment of Rehabilitation, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University, Shenzhen, Guangdong, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Research into the effect of high-density lipoprotein cholesterol (HDL-C) on metabolic dysfunction-associated steatotic liver disease (MASLD) remains relatively limited. This research aims to shed light on how HDL-C levels correlate with MASLD among the Japanese demographic. Methods: A comprehensive review of health records from 14,280 patients at Murakami Memorial Hospital from 2004 to 2015 was undertaken. To investigate the linear association of HDL-C concentrations with MASLD occurrence, binary logistic regression was applied. Additionally, a generalized additive model (GAM) integrated with smooth curve fitting procedures was implemented to characterize potential non-linear dependencies. Results: An inverse correlation was observed between HDL-C levels and MASLD prevalence (OR = 0.46; 95% CI: 0.37-0.58), holding steady after adjustments for various demographic and health variables. The consistency of these findings was confirmed through multiple sensitivity tests. The study also uncovered a non-linear correlation between HDL-C concentrations and MASLD occurrence. A detailed analysis using a two-piece logistic regression and recursive techniques pinpointed a critical HDL-C level of 1.04 mmol/L. Above this level, each unit increase in HDL-C was linked to a 61% decrease in the likelihood of MASLD (OR = 0.39; 95% CI: 0.30-0.50), a connection that dissipates below this threshold of HDL-C (OR = 1.49; 95% CI: 0.66-3.35). Conclusion: The investigation revealed an inverse, non-linear relationship between HDL-C and MASLD within the Japanese community, emphasizing a pivotal threshold effect. Elevated HDL-C levels beyond 1.04 mmol/L significantly diminish MASLD risk.

Indexed as

generalized additive modelhigh-density lipoprotein cholesterollipidmetabolic dysfunction-associated steatotic liver diseasenon-linearity

Identifiers

PMID41743086
PMCPMC12929366

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.